Phase IIb Clinical Trial Results A variety of HLA types are predicted to associate with GP2 based on binding algorithms, and such binding can be tested in preclinical experiments. However, HLA-A*02 is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback